Anonymous
Guest
Anonymous
Guest
So the launch of our new drug will soon be here. What are the challenges? First, you must be over 100% with Vesicare to earn bonus dollars with our new product. Take into account about half or a little more of the reps are above goal now. You will not be able to grab low hanging fruit from Vesicare. It must all come from competitors or by expanding the market. Take into account the following, both these drugs will have the same exact indication for the same disease state. Also, the OAB market has been in decline for about 5 years. We also have 23 million americans out of work. This is the first time in my career I can't go out there and just sell the drug to everybody.
Astellas has really gone out of the way to limit the bonus dollars with the new product by creating the 100% rule with Vesicare.
Our launch is going occur in the middle of the donut hole. What I am trying to say is we have to be perfect to have some success. No one seems to challenge any of this. I saw and heard a rep. challenge or debate a manager at a hub meeting, now the rep is disliked among this group of managers. I just do not understand.
Marketing even got upset when asked about the spelling of the name. I can't have this conversation with my manager because I would be fired.
Astellas has really gone out of the way to limit the bonus dollars with the new product by creating the 100% rule with Vesicare.
Our launch is going occur in the middle of the donut hole. What I am trying to say is we have to be perfect to have some success. No one seems to challenge any of this. I saw and heard a rep. challenge or debate a manager at a hub meeting, now the rep is disliked among this group of managers. I just do not understand.
Marketing even got upset when asked about the spelling of the name. I can't have this conversation with my manager because I would be fired.